To investigate the role of the presumed DNA mismatch repair (MMR) gene Msh2 in genome stability and tumorigenesis, we have generated cells and mice that are deficient for the gene. Msh2-deficient cells have lost mismatch binding and have acquired microsatellite instability, a mutator phenotype, and tolerance to methylating agents. Moreover, in these cells, homologous recombination has lost dependence on complete identity between interacting DNA sequences, suggesting that Msh2 is involved in safeguarding the genome from promiscuous recombination. Msh2-deficient mice display no major abnormalities, but a significant fraction develops lymphomas at an early age. Thus, Msh2 is involved in MMR, controlling several aspects of genome stability; loss of MMR-controlled genome stability predisposes to cancer.
Introduction
Cancer is the endpoint of an evolutionary process in which normal cells acquire full malignancy by cumulative genetic or epigenetic alterations, each conferring proliferative, invasive, or metastatic potential to the cell. In colorectal cancer, at least six independent transforming mutations in oncogenes or tumor suppressor genes are required for a cell to develop into a fully malignant tumor (reviewed by Vogelstein and Kinzler, 1993) . This evolutionary process might be dramatically accelerated by the early loss of systems that safeguard genome stability, resulting in an increased rate of mutagenesis and chromosomal rearrangements (Hartwell, 1992; Loeb, 1994) . In support of this hypothesis, a number of hereditary cancer predisposition syndromes are attributed to defects in DNA repair. Two of these are hereditary nonpolyposis colorectal cancer (HNPCC) and Muir-Torre syndrome, which are characterized by the development of tumors of the proximal colon at early age. Cancers of other parts of the gastrointestinal tract and of the genitourinary tract are also often found . Muir-Torre patients are, in addition, prone to cancers of the sebaceous glands and the skin (Cohen et al., 1991) . Individuals affected by one of these syndromes have most likely inherited a mutant allele of either one of four mismatch repair (MMR)-related genes, MSH2, MLFI1, PMS1, or PMS2 (Leach et al., 1993; Bronner et al., 1994; Kolodner et al., 1994 Kolodner et al., , 1995 Liu et al., 1994; Nicolaides et al., 1994; Papadopoulos et al., 1994; reviewed by Jiricny, 1994 ; reviewed by Modrich, 1994) . In tumors of these patients, MMR is lost, presumably through inactivation or loss of the wild-type allele (Leach et al., 1993; Nicolaides et al., 1994; Papadopoulos et al., 1994; Hemminki et al., 1994) . The mechanisms of loss of MMR, the cause of the apparent tissue specificity of tumorigenesis, and the role of loss of MMR in the evolution of a normal cell to fully malignant tumors are still obscure. Moreover, recent data suggest that MMR is frequently lost in many types of sporadic tumors (Han et al., 1993; Parsons et al., 1993; Risinger et al., 1993; Chong et al., 1994; Mironov et al., 1994; Orth et al., 1994; Shibata et al., 1994; Suzuki et al., 1994; U mar et al., 1994b; Wada et al., 1994; Wooster et al., 1994; Liu et al., 1995) . This supports the notion that loss of MMR may play a general role in tumor evolution.
The best-studied MMR system with respect to both genetics and biochemistry is the mutSL pathway of Escherichia coli (reviewed by Modrich, 1991) . Central in this pathway is the protein encoded by the mutS gene, which binds to base mispairs and to loops of up to four unpaired nucleotides. After binding to the heteroduplex, the MutS-DNA complex is bound by the mutL gene product, triggering excision of a tract of single-stranded DNA of up to several kilobases that contains the mismatched nucleotide(s). The repair process is completed by resynthesis of the excised DNA strand and ligation of the remaining nick. MMR in E. coli is responsible for maintaining genome integrity in at least two ways: by recognizing and repairing mispaired and extrahelical nucleotides that occur by, respectively, misincorporation and slippage during replication and by recognizing mismatches occurring in recombination intermediates between homologous but diverged sequences, leading to abortion of recombination. Consequently, E. coli strains deficient for either mutS or mutL have a pleiotropic phenotype: an increased mutation rate, including destabilization of simple-sequence repeats (also called microsatellites; the replication error-positive [RER ÷] phenotype) and promiscuity in inter-and intragenomic recombination (the recombinator phenotype; Rayssiguier et al., 1989; Petit et al., 1991) .
In many respects, the biochemistry of MMR systems in eukaryotes resembles that of the mutSL system (Holmes et al., 1990; Varlet et al., 1990; Thomas et al., 1991; Fang and Modrich, 1993 (Varlet et al., 1994) . The position at which the protein is disrupted by insertion of the hyg marker is indicated. (Bottom) The genomic Msh2 locus; indicated below is the targeting construct carrying the hyg marker inserted into a unique SnaBI site within an exon sequence of Msh2. The positions of the external probes used for detection of targeting events are indicated. (B) The Msh2 locus in Msh2 +~÷ cell line wt-2, Msh2 +j-cell line sMsh2-55, and Msh2 ÷ cell line dMsh2-9. Genomic DNA of these cell lines was digested with EcoRI and analyzed by Southern blot hybridization using probe 1, as shown in (A). Arrowheads indicate the positions of the wild-type (wt) (20 kb) and disrupted (ko) (7.5 kb) alleles.
seems to be the functional homolog of MutS (Reenan and Kolodner, 1992b; Miret et al., 1993; Alani et al., 1995) . In higher eukaryotes (Xenopus laevis, mouse, and human), homologs of the yeast MSH2 gene have recently been identified, based on either sequence homology, direct sequencing of the major mismatch-binding protein, or positional cloning (Fishel et al., 1993; Leach et al., 1993; PaIombo et al., 1994; Varlet et al., 1994 ). An apparent difference between MutS and MSH2 is the binding of the eukaryotic protein, when overproduced and purified from E. coli or yeast, to stretches of up to 14 extrahelical nucleotides (so-called insertion/deletion-type loops [IDLs] ) in vitro (Fishel et al., 1994b; Alani et al., 1995) , suggestive of a role for MSH2 in the repair of these loops (Umar et al., 1994a) . Eukaryotic homologs of the mutL gene, MLH1, PMS1, and PMS2, have been analyzed in yeast (Kramer et al., 1989a (Kramer et al., , 1989b Strand et al., 1993; Prolla et al., 1994a Prolla et al., , 1994b and human cells.
The precise role of these mutS and mutL homologs in MMR and the role of MMR in the maintenance of genome stability in mammalian cells remain to be established. In addition, the causative role of MMR in cellular sensitivity to simple methylating agents, as was suggested by the loss of MMR after selection of cells for tolerance to these agents (Branch et al., 1993; Kat et al., 1993) and by the methylation tolerance of a MMR-deficient tumor cell line (Koi et al., 1994) , remains to be explored.
To investigate the involvement of MSH2 in mammalian MMR and the roles of MMR in maintaining genome stability, we have generated mouse embryonic stem (ES) cell lines that lack both copies of the Msh2 gene. We show that Msh2-deficient cells lack binding to some specific mismatches, have acquired a mutator phenotype, and are tolerant to simple methylating agents. Moreover, these cells have lost the barrier to recombination between homologous but diverged sequences. Taken together, these results suggest that MMR is essential for the preservation of multiple aspects of genome stability in mammalian cells.
To study the effect of MMR deficiency on the etiology and evolution of cancer, we generated mice lacking one or both copies of the Msh2 gene in part or all of their cells. Although heterozygous mice, a model for H N PCC, remain healthy to at least 8 months of age, a significant fraction of both chimeric and fully homozygous Msh2 knockout mice succumbs to lymphomas. These results provide evil dence that loss of MMR-controlled genome stability can accelerate the development of cancer.
Results
Targeted Disruption of the M s h 2 Gene in Mouse ES Cells Heterozygous ES cell lines sMsh2-42 and sMsh2-55, carrying a hygromycin (hyg) resistance gene inserted between codons 588 and 589 of one allele of the Msh2 gene, were generated by gene targeting using the construct shown in Figure 1A . Cell line dMsh2-9, carrying the hyg marker in both alleles of the Msh2 gene, was obtained by selecting cell line sMsh2-55 for duplication of the chromosome carrying the targeted Msh2 allele at an elevated hygromycin B concentration, a method that was previously shown to be effective using the neomycin (neo) resistance marker (Mortensen et al., 1992) . Targeting events were detected by Southern blot analysis, using probes flanking both sides of the targeting construct ( Figure 1A ). An example of such a Southern blot, demonstrating the status of the Msh2 alleles in cell lines wt-2 (a control cell line with the targeting construct integrated by nonhomologous recombination), sMsh2-55, and dMsh2-9, is shown in Figure  1 B. Diploidy of cell lines sMsh2-55 and dMsh2-9 was verified by karyotyping (data not shown).
The hyg marker was inserted, in the antisense orientation, N-terminally of the putative ATP-binding site ( Figure  1A ) in a region where (in the human gene) truncations were found in many HNPCC tumors . Moreover, no Msh2 transcript could be detected in ES cell line dMsh2-9 by Northern blotting (data not shown), indicating that the hyg marker strongly suppressed Msh2 expression. The genotype of ES cell line dMsh2-9 will therefore be indicated by Msh2 -~-.
Mismatch Binding in M s h 2 -~-Cells
Two different mismatch-binding activities have been determined in mammalian cell extracts through the use of gel retardation assays: one activity recognizes G-T mismatches (Jiricny et al., 1988; Stephenson and Karran, 1989; Griffin and Karran, 1993) , an extrahelical TG dinucleotide (Aquilina et al., 1994) representing an intermediate in replicational slippage of a microsatellite, and, weakly, G .A, G-G, A. C, and G. U mismatches (Stephen- (Extrahelical  TG) , or an extrahelica114 nt loop (LOOP14) and a homoduplex was assessed using a gel retardation assay. Sequences of the oligonucleotides are given in Experimental Procedures. Arrowheads indicate the positions of mismatch-specific complexes. E2F indicates binding to an oligonucleotide carrying an E2F site, which served as a positive control (Beijersbergen et al., 1995) .
son and Karran, 1989; Hughes and Jiricny, 1992) , while, in one cell line, an independent activity recognizes A.C mismatches and also pyrimidine, pyrimidine mismatches (Stephenson and Karran, 1989) . Based on protein sequencing, the purified G-T-binding activity was shown to contain the MSH2 protein (Palombo et al., 1994) . To characterize the mismatch binding properties of the Msh2 -~-ES cell line, we have performed gel retardation assays using cell extracts of wild-type ES cell line wt-2 and Msh2-deficient line dMsh2-9. Extracts were incubated with radiolabeled 38-mer double-stranded oligonucleotides containing either a mismatch, an extrahelical dinucleotide, or a 14 nt IDL, followed by electrophoresis on a nondenaturing polyacrylamide gel. Results of these experiments, as shown in Figure 2 , clearly demonstrate binding activity in wild-type cell extracts to a G-T mismatch and to an extrahelical TG dinucleotide. Binding to both oligonucleotides was entirely absent in the extract of the Msh2 -~-ES cell line, demonstrating the involvement of the MSH2 protein in this binding activity. As shown before (Hughes and Jiricny, 1992) , binding was abolished by the inclusion of ATP in the binding reaction (data not shown). We were unable to detect specific binding to G.A, G.G, or A.C mismatches under the conditions used in wild-type or mutant cell extracts. In addition, no MSH2-dependent binding to a 14 nt IDL was observed ( Figure 2) .
M s h 2 -~-Cells Have a M u t a t o r P h e n o t y p e
The Msh2 -j-cell line was indistinguishable from the wildtype cell line wt-2 and the parental heterozygous cell line sMsh2-55 with respect to growth and plating efficiency (data not shown), To address the role of MSH2 in MMR, we determined the stability of two microsatellite markers in Msh2 -~-cell line dMsh2-9 and Msh2 +1÷ line wt-2. For this purpose, 24 subclones were derived of each cell line, which had undergone approximately 20 cell divisions since its generation. Chromosomal DNA, isolated from each expanded subclone, was subjected to the polymerase chain reaction (PCR) using two end-labeled primer pairs (D7Mit17 and D14Mit15; Dietrich et al., 1994) . Whereas none of the wt-2 sublines showed any alteration in microsatellite length, clear length alterations in many dMsh2-9 sublines were seen for both microsatellites (8 out of 24 for marker D 7 M i t 1 7 and 6 out of 24 for marker D14Mit15; Figure 3 ). This observation strongly suggests that the MSH2 protein is involved in the repair of slipped replication intermediates. The microsatellite-slippage rate was estimated to be 10 -2 to 10 -3 per generation. We subsequently investigated the effect of loss of the Msh2 gene on the mutation frequency of a functional gene. To this purpose, 6 x 106 cells of cell lines wt-2 and dMsh2-9 were plated in the presence of 6-thioguanine to select for cells that have lost activity of the X-linked Hprt gene by mutation. Whereas no 6-thioguanine-resistant colonies were seen in the wt-2 culture, 188 resistant colonies were present in the dMsh2-9 culture. This result extends the mutator phenotype of Msh2 -~-cells to functional genes.
M s h 2 -j-Cells A r e Tolerant to N-MethyI-N'-Nitro-N-Nitrosoguanidine
MMR was suggested to mediate hypersensitivity to agents that methylate G residues at the 06 position (O6-meG). It is believed that MMR recognizes the OS-meG-T mispair that occurs after erroneous incorporation of a thymidine nucleotide opposite to O6-meG during replication (Griffin 
[MNNG], ~a et al., 1994) . This is supposedly followed by excision and repair synthesis, again incorporating thymidine opposite to O6-meG, triggering a new round of MMR. The net result of this cycling between excision and resynthesis will be the presence of single-stranded regions at the site of O6-meG residues that will lead to double-stranded gaps when replicated during S phase, resulting in cell death (reviewed by Bignami, 1992, 1994) . It is predicted that loss of MMRwill prevent this process, thus conferring tolerance to simple methylating agents. To test this hypothesis directly, we determ ined survival of Msh2 -~-cell line dMsh2-9, Msh +~-cell line sMsh2-21, and wild-type cell line wt-2 after exposure to a range of concentrations of N-m ethyI-N'-nitro-N-nitrosoguanidine (MNNG). In the growth medium, 06-benzylguanine was included to inhibit endogenous methyltransferase activity competitively that might otherwise remove the methyl groups added by MNNG (Dolan et al., 1990) . Figure 4 shows that the LD~o for MNNG was increased 20-fold in the Msh2 -~-cell line compared with the heterozygous and wild-type cell lines, directly proving the involvement of MSH2 in determining cellular sensitivity to MNNG. Heterozygous cell line sMsh2-21 displayed no increased tolerance to MNNG.
Loss of Suppression of Recombination between Diverged Sequences in Msh2 -~-Cells
In E. coil (Shen and Huang, 1986) , Drosophila (Nassif and Engels, 1993) , and mammalian cells (Waldman and Liskay, 1988; te Riele et al., 1992) , the efficiency of recombination between homologous DNA stretches is highly dependent on their sequence identity. We have previously demonstrated that in a gene targeting assay, homologous recombination at the retinoblastoma (Rb) locus in ES cells, derived from mouse strain 129, was 50-fold more efficient with a 129-derived targeting construct than with a construct derived from a nonisogenic (BALB/c) mouse strain (te Riele et al., 1992; Table 1 ). This construct contained 0.6% base sequence divergence with respect to the isogenic 129 construct. To provide additional evidence that suppression of recombination was solely dependent on the polymorphisms between the endogenous locus and the targeting DNA, we performed the inverse experiment, i.e., targeting of a BALB/c-derived ES cell line with the 129-and BALB/c-derived constructs. This experiment yielded the inverse result, i.e., a higher targeting efficiency with the BALB/c targeting construct than with the nonisogenic 129 targeting construct (Table 1) . To investigate whether MMR is responsible for this antirecombination effect, we have repeated the Rb targeting experiment in the (129-derived) ES cell line dMsh2-9. We found that in the Msh2 -j-cell line, homologous recombination at the Rb locus with the nonisogenic construct was as efficient as with the isogenic construct (Table 1 ). This experiment demonstrates that MSH2 is involved in preventing homologous recombination between diverged DNA sequences.
Msh2-Deficient Mice Are Viable but Predisposed to Tumorigenesis
To study the effect of MMR deficiency on the development of cancer, Msh2 +~-ES cell lines sMsh2-55 and sMsh2-42 and Msh2 -~-ES cell line dMsh2-9 were used to generate chimeric mice. Both the Msh2 single and double knockout ES cells gave rise to healthy animals with coat-color chimerism of 20%-70%. This result suggests that MMR deficiency did not alter the capacity of the ES cells to compete with wild-type cells in chimeric development. Msh2 ÷~-chimeras were found to transmit the mutant allele through the germline, resulting in Msh2 heterozygous F1 mice. These mice, which may serve as a model for HNPCC, were healthy up to at least 8 months of age ( Table 2) .
Intercrossing of Msh2 ÷~-mice resulted in Msh2 -~-mice according to a normal Mendelian distribution; they were healthy at birth and fertile. However, 30% of the Msh2 -~-mice developed metastasizing lymphomas of T cell origin, with a peak at 2 months of age (Table 2 ). In addition, one mouse suffered from generalized histiocytic sarcoma at Number of mice carrying a tumor per total number in the experiment. b Chimeras consisting of wild-type and Msh2 -j-cells.
3.5 months of age. Extensive histological analyses of these mice did not reveal any other abnormality. Also, healthy Msh2 + mice sacrificed at 2 months of age were histologically normal and had normal B cell and T cell populations as evidenced by fluorescence-activated cell sorting (FACS) analysis.
Discussion

Lack of Mismatch Binding in Msh2 + Cell Extracts
Whereas wild-type cell extracts display efficient binding to both a G.T mismatch as well as to an extrahelical TG dinucleotide, extracts of the ES cell line dMsh2-9 lack this binding (Figure 2) , suggesting that the MSH2 protein is essential for binding to these heteroduplexes. We were unable to detect specific binding activity to other mismatches under the conditions used. This result is compatible with binding studies by others that demonstrate that binding to a G .T mismatch is stronger than to other mismatches (Stephenson and Karran, 1989; Hughes and Jiricny, 1992) , whereas the independent A. C binding activity is apparently cell-type specific (Jiricny et al., 1988; Stephenson and Karran, 1989) . The methylation-tolerant cell lines clone B and RajiF12 were also found to lack binding both to a G .T mismatch (Branch et al., 1993; Griffin et al., 1994) and to an extrahelical TG dinucleotide (Aquilina et al., 1994) . Binding to an A.C mismatch was unaffected (Branch et al., 1993) . Therefore, these cell lines may have lost the Msh2 gene. Purified human MSH2, overproduced in E. coil, and purified yeast MSH2 were shown to bind to G. T mismatches (Fishel et al., 1994a; Alani et al., 1995) , but also strongly to IDLs of up to 14 nt (Fishel et al., 1994b; Alani et al., 1995) . Surprisingly, we could not detect MSH2-dependent binding to a 14 nucleotide IDL in ES cell extracts. We are unable to explain this apparent discrepancy. In contrast with the binding that we observed in ES cell extracts and that of the GTBP protein, the MSH2-containing G.T mismatch-binding protein fraction purified from HeLa cells (Hughes and Jiricny, 1992; PaIombo et al., 1994) , the binding capacity of the purified MSH2 proteins was not abolished by ATP (Fishel et al., 1994b; Alani et al., 1995) . This suggests that the purified MSH2 proteins behave differently from the naturally produced protein. The finding that in Msh2 + cells length shifts in microsatellites were never larger than 4 nt (representing two CA dinucleotides; Figure 3) suggests that binding activity of MSH2 to extrahelical loops longer than 4 nt is not required to maintain microsatellite stability. We are currently initiating in vitro repair assays using wild-type and Msh2 + cell extracts to elucidate this point further.
Mutator Phenotype of Msh2.Deficient Cells
Cell line dMsh2-9 had acquired microsatellite instability (the RER ÷ phenotype), indicating failure to repair slipped replication intermediates. The frequency of microsatellite instability was similar to that of some RER + tumor cell lines (Parsons et al., 1993; Bhattacharyya et al., 1994) . The mutator phenotype of these cells also affects functional genes as evidenced by the rate of Hprt deficiency in a dMsh2-9 culture that was increased from undetectable (i.e., lower than 1.6 x 10 -7) for wild-type cells to 3 x 10 -5. This frequency is in agreement with that found in some RER ÷ tumor cell lines (Bhattacharyya et al., 1994; Shibata et al., 1994; Eshleman et al., 1995) , although cell lines that have been selected for MMR deficiency using a methylating agent tend to have somewhat lower mutation frequencies (Goldmacher et al., 1986; Branch et al., 1993; Kat et al., 1993; Aquilina et al., 1994) . Growth rate and plating efficiency of Msh2-deficient, heterozygous, and wild-type cells were indistinguishable, suggesting that the mutator phenotype does not interfere with viability of the cells. This is remarkable, since both were seriously affected in some cell lines that were selected for MMR deficiency using methylating agents (Goldmacher et al., 1986) . This suggests that in the latter cells, additional events may have taken place that interfere with cell viability. Based on the mutator phenotype of dMsh2-9 cells and on the binding studies described above, we conclude that MSH2 is involved in and essential for postreplicational MMR.
Sensitivity to Simple Methylating Agents Is Mediated by MMR
Sensitivity of cells to agents that methylate DNA at the 06 position of G residues has been attributed to futile attempts of MMR to correct the resulting O6-meG • T basepairs (see Results). This hypothesis is supported by two observations. First, prolonged selection of cells for tolerance to methylnitrosourea or MNNG frequently results in loss of MMR (Kat et al., 1993) and loss of G.T-binding activity (Branch et al., 1993; Griffin et al., 1994) . Second, an RER ÷ tumor cell line was found to be tolerant to these agents, and sensitivity was restored by introduction of the chromosome containing a wild-type allele of the defective MMR gene (Koi et al., 1994) . Our finding that that Msh2-deficient cell line dMsh2-9 had acquired tolerance to MNNG pro-vides direct evidence in support of this hypothesis. This finding may have important clinical implications. The triazene class of carcinostatic drugs probably derives its cytotoxic effect from methylation at the 06 position of G residues (Michejda et al., 1994) . Whereas MMR-deficient tumors are supposedly tolerant to these drugs, they may elicit severe cytotoxity in normal tissues of the patient. In addition, the persistence of O6-meG • T mispairs in MMRdeficient tumor cells might lead to increased G to A transitions , resulting in acceleration of tumor progression. Finally, the finding that simple methylating agents select (or induce) MMR deficiency in cells has led to the hypothesis that this process is involved in determining the tisssue specificity of tumorigenesis in HNPCC patients, owing to the presence of such agents in the intestine Varlet et al., 1994) .
MMR Edits Homologous Recombination in Mammalian Cells
Previously, it has been shown that the presence of less than 1% nucleotide difference can strongly suppress homologous recombination in mammalian cells (Waldman and Liskay, 1988; te Riele et al., 1992) . Here, we have extended these results, and we have demonstrated that Msh2 -~-cells have lost this heterology-dependent suppression of recombination. Based on results obtained in E. coil (Worth et al., 1994) , we have concluded that this function is probably mediated by the MSH2 protein by recognizing mismatches that occur during heteroduplex formation between two not perfectly complementary DNA strands. This may directly destabilize the heteroduplex or, alternatively, prevent elongation of strand exchange. Similar results have recently been obtained with MSH2-deficient yeast strains (Alani et al., 1994; Selva et al., 1995) , suggesting that this role of MMR is strongly presewed during evolution. In E. coil, loss of MMR has been shown to result in a high frequency of inter-and intrachromosomal rearrangements owing to ectopic recombination between diverged sequences (Rayssiguier et al., 1989; Petit et al., 1991) . More than the E. coil genome, mammalian genomes contain many repeated but diverged sequences. Examples of these are gene families, SINE sequences, LINE sequences, and pseudogenes (Brosius and Gould, 1992; Nowak, 1994) . Ectopic recombination between these sequences would lead to genomic rearrangements that may either be detrimental for cell viability due to loss of essential genomic information or, alternatively, lead to activation of oncogenes or inactivation of tumor suppressor genes (Bouffler et al., 1993) . Homologous recombination between identical DNA stretches should be allowed to proceed, however, to allow recombinational repair of double strand breaks using the (identical) sister chromatid as sequence donor. For this reason, mechanisms counteracting homologous recombination when both recombining stretches contain divergencies, while permitting recombination to proceed when both stretches are identical, may be of great importance for the mammalian cell to enable repair without risking genome rearrangment. Based on the effect of Msh2 deficiency on gene targeting, it is likely that MMR plays this scrutinizing role.
Our finding that Msh2 acts not only antimutagenically but also antirecombinogenically suggests that MMR deficiency may contribute to tumorigenesis by elevating the rate of both point mutations and chromosomal rearrangements.
Role of Msh2 Deficiency in Tumorigenesis
Msh2 deficiency did not interfere with mouse embryonic development and is compatible with adult life. This observation substantiates the recent finding that some HNPCC patients seem largely MMR deficient in normal cells . A significant fraction of chimeric and pure Msh2 -~-mice developed metastasizing lymphomas. It is likely that the developing immune system in newborn mice, in which a high turnover of maturing T cells exists, offers a window in which MMR deficiency can strongly accelerate the accumulation of transforming events.
The basal level of mutagenesis in the cell, estimated to be approximately 10 -1° per nucleotide per generation, is considered to be insufficient to sustain the m ultistep clonal outgrowth of cells in tumorigenesis (Loeb, 1994) . Therefore, an increased mutation rate, such as caused by MMR deficiency, is likely to be obligatory to accelerate this process (Loeb, 1994) . Our results suggest that a rapid cell expansion is required to unveil the effect of MMR deficiency on tumor development. Corroborating this notion, recent studies of microsatellite instability during cancer development show that loss of MMR probably does not occur as the initial step, but rather within an early tumor stage, such as an adenoma (Young et al, 1993; Aaltonen et al., 1994; Chong et al., 1994; Shibata et al., 1994; Wada et al., 1994) , which, in HNPCC patients, has been found to evolve rapidly into carcinomas Jass et al., 1994) . Moreover, two recent studies support the notion that enhanced mutagenesis due to MMR deficiency is responsible for tumor progression. In the first study, some RER + tumors had acquired frameshift mutations in the ~2-microglobulin gene within a CT repeat, indicative of unrepaired replication slippage and putatively leading to escape from immune surveillance (Bicknell et al., 1994) ; in the second study, in some RER ÷ colon carcinomas from HNPCC patients, p53 and APC were found to contain either frameshifts in repeated nucleotides or G to A transitions, indicative of the failure to repair slipped simple sequence repeats and G-T mismatches, respectively (Lazar et al., 1994) .
In conclusion, our studies on Msh2 deficiency prove the involvement of Msh2 in MMR and show that MMR functions as a mechanism safeguarding the mammalian genome against mutation by misincorporation and recombination between diverged sequences. In addition, our results lend support to the hypothesis that MMR deficiency can strongly accelerate malignant transformation of rapidly expanding cell populations.
Experimental Procedures
Disruption of Msh2 in Mouse ES Cells
Genomic Msh2 fragments were obtained by screening a 129/OLA-derived genomic DNA library with a murine Msh2 cDNA probe (Varlet et al., 1994) . The targeting construct was prepared by subcloning a 12.5 kb BamHI fragment and inserting a hyg resistance gene (from PGK-hyg; te Riele et al., 1990) into the unique SnaBI site located within an exon sequence of Msh2. Cloning procedures were performed according to Sambrook et al. (1989) .
The targeting construct was separated from vector sequences by gel electrophoresis, purified by electroelution, and introduced into 129/ OLA-derived ES cell line E14 by electroporation as described previously (te Riele et al., 1992) . Electroporated cells were seeded onto gelatin-coated 10 cm dishes (107 cells per plate) and subjected to hygromycin B selection (150 ~g/ml) in BRL-conditioned medium (Hooper et al., 1987 ) the following day. After 10 days, individual hygromycin B-resistant colonies were randomly picked and expanded on mouse embryonic fibroblasts feeder layers. DNA was extracted from expanded colonies, digested with EcoRI, and analyzed by Southern blot hybridization using probes flanking both sides of the targeting construct ( Figure 1A) . Two cell lines were obtained out of 135 hygromycin B-resistant colonies showing bands diagnostic for correct integration of the hyg marker between codons 588 and 589 of one copy of the Msh2 gene. These cell lines were designated sMsh2-42 and sMsh2-55. One cell line obtained from this experiment, designated wt-2, carrying a randomly integrated hyg gene, was used as an Msh2 *~+ control.
To obtain an ES cell line carrying a disruption in both copies of Msh2, 106 cells of cell line sMsh2-55 were plated onto 10 cm plates and cultured in BRL-conditioned medium containing 1.0 or 1.5 mg/ml of hygromycin B. After 12 days of culturing in selective medium and 7 days in nonselective medium, 24 colonies were obtained that had survived 1.5 mg/ml of hygromycin B. DNA was extracted from expanded colonies, digested with EcoRI, and analyzed by Southern blot hybridization. One cell line, designated dMsh2-9, carried two disrupted Msh2 alleles, had lost the wild-type copy, and contained the normal number of chromosomes. ES cell lines that had survived 1.0 mg/ml of hygromycin B still contained one disrupted and one wild-type Msh2 copy. One of these Msh2 +j-lines was designated sMsh2-21 and used for several experiments.
Generation of Msh2 Mutant Mice
Chimeric mice were obtained by injecting 10-15 cells of ES cell lines sMsh2-55, sMsh2-42, and dMsh2-9 into C57BL/6 blastocysts. Male chimeras obtained with Msh2 +~-ES cells were crossed with wild-type 129/OLA and FVB mice and found to transmit the mutated Msh2 allele through the germline. Homozygous Msh2 mutant mice were obtained by intercrossing F1 heterozygotes.
Gel Shift Assay
Preparation of cell extracts, annealing of oligonucleotides, binding of cell extracts to duplex oligonucleotides containing mismatched or extrahelical nucleotides, and nondenaturing polyacrylamide gel electrophoresis were performed essentially as described previously (Stephenson and Karran, 1989) . However, gel electrophoresis was performed in TAE buffer rather than in TBE buffer. To obtain duplex oligonucleotides, we radiolabeled and annealed the oligonucleotide U (5'-GGGAAGCTGCCAGGCCCCAGTGTCAGCCTCCTATGCTC-3'; (sequences were derived from Aquilina et al., 1994) with any of the following unlabeled oligonucleotides: L-G.T, 5'-GAGCATAGGAGGC-TGACATTGGGGCCTGGCAGCTTCCC-3' (resulting in a G.T mismatch); L-G.A, 5'-GAGCATAGGAGGCTGACAATGGGGCCTGGCA-GCTTCCC-3' (resulting in a G.A mismatch); L-G.G, 5'-GAG-CATAGGAGGCTGACAGTGGGG CCTGGCAGCTTCCC-3' (resulting in a G.G mismatch); L-A. C, 5'-GAGCATAGGAGGCTGACACCGGGG-CCTGGCAGCTTCCC-3' (resulting in an A.C mismatch); L-TG, 5'-GAGCATAGGAGGCTGACACTGTGGGGCCTGGCAGCTTCCC-3' (resulting in an extrahelical TG dinucleotide); L-HOM, 5'-GAG-CATAGGAGGCTGACACTGGGGCCTGGCAGCTTCCC-3' (resulting in a homoduplex); L-LOOP14, 5'-GAGCATAGGAGGCTGACACATAC-GTGAGTACTCTGGGGCCTGGCAGCI-FCCC-3' (resulting in an IDL loop of 14 extrahelical nucleotides). In all assays, a 2-fold excess of unlabeled homoduplex competitor oligonucleotide was included. As a positive control, a duplex oligonucleotide containing the binding site for the E2F family of transcription factors was used (Beijersbergen et al., 1995) .
PCR Amplification of Microsatellites
Subclones of ES cell lines dMsh2-9 and wt-2 were generated by seeding cells onto mouse embryonic fibroblasts feeder layers at a density of 103 cells per 10 cm 2, At that time, the ES cell lines were in culture for approximately 20 divisions since their generation; 24 colonies from each cell line were expanded. Chromosomal DNA was isolated and subjected to PCR using two end-labeled primer pairs (D14Mit15 and D7Mit17; Dietrich et al., 1994) . Amplified products were electrophoresed on a denaturing polyacrylamide gel.
Mutation Frequency
Cells (6 x 106) of ES cell lines dMsh2-9 and wt-2 were plated onto 486 cm 2 gelatin-coated tissue culture surface in BRL-conditioned medium. After 2 days, 6-thioguanine was added at a concentration of 10 pg/ ml. After 2 weeks, the number of resistant colonies was counted.
Sensitivity to MNNG ES cell lines dMsh2-9, sMsh2-21, and wt-2 were seeded onto MEF feeder layers at a density of 103 cells per 4 cm 2, The following day, cells were exposed for 1 hr to MNNG ranging in concentration from 0 to 36.45 pM in serum-free medium. After 4 days of incubation, cells were trypsinized, stained with trypan blue, and counted. During the whole procedure from 1 hr before exposure to MNNG, O6-benzylguanine (20 ~M; provided by A. Pegg) was included in the medium to inhibit endogenous methyltransferase activity competively that might otherwise remove the methyl groups added by MNNG (Dolan et al., 1990) .
Rb Targeting with Isogenic and Nonisogenic DNA Targeting and subsequent analysis of the Rb locus in a BALB/c-derived ES cell line (provided by S. Rastan) and the 129/OLA-derived ES cell line dMsh2-9 were performed essentially as described previously (te Riele et al., 1992) . The targeting constructs 129Rb-neo (derived from the 129/OLA genome) and B/cRb-neo (derived from the BALB/c gehome) carry an insertion of the pMCl-neo marker in exon 19 of the Rb gene and differ approximately 0.6% at the nucleotide level (te Riele et al., 1992) .
